<DOC>
	<DOCNO>NCT02300012</DOCNO>
	<brief_summary>Incident rate ACL rupture great 16-39 year old almost 1 1,000 . Performance Based Investigations ( PBIs ) use evaluate select correct approach patient treatment , biochemical , biomechanical physiological biomarkers condition sensitive distinguish disease state severity , type injury responsiveness treatment . Despite measurement sensitivity PBIs , widely use possibly owe focus postoperatively benefit less worthwhile . This study aim investigate novel biomarkers performance base investigation ( PBIs ) improve surgical treatment strategy anterior cruciate ligament ( ACL ) patient . The objective identify whether biomarkers , collect operation , : 1 ) Assist surgeon decision making; 2 ) Lead improve prognosis; 3 ) Be use predict outcome prognosis , and; 4 ) Correlate disease signs/ smoke help understand ACL injury .</brief_summary>
	<brief_title>A Pilot Study Investigate Biomarkers Anterior Cruciate Ligament ( ACL ) Patients Healthy Controls</brief_title>
	<detailed_description />
	<mesh_term>Rupture</mesh_term>
	<criteria>unilateral ACL rupture 18 45 year old combine posterior ACL rupture multiligament instability include medial lateral collateral ligament injury lower limb surgery &lt; 3mths current significant acute injury affect low extremity joint , relevant neurological musculoskeletal pathology .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Anterior cruciate ligament</keyword>
	<keyword>Performance base investigation</keyword>
</DOC>